• Users Online: 173
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Browse Articles Search Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2018  |  Volume : 9  |  Issue : 1  |  Page : 16

Health care of elderly: A viewpoint in terms of economic evaluation

Department of Community Medicine, Mahatma Gandhi Medical College and Research Institute, Puducherry, India

Date of Submission17-Oct-2016
Date of Acceptance22-Jun-2017
Date of Web Publication08-Feb-2018

Correspondence Address:
Suguna Anbazhagan
Department of Community Medicine, Mahatma Gandhi Medical College and Research Institute, Cuddalore Main Road, Pillaiyarkuppam, Puducherry - 607 402
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijpvm.IJPVM_357_16

Rights and Permissions

How to cite this article:
Anbazhagan S, Surekha A. Health care of elderly: A viewpoint in terms of economic evaluation. Int J Prev Med 2018;9:16

How to cite this URL:
Anbazhagan S, Surekha A. Health care of elderly: A viewpoint in terms of economic evaluation. Int J Prev Med [serial online] 2018 [cited 2022 Aug 14];9:16. Available from: https://www.ijpvmjournal.net/text.asp?2018/9/1/16/225040

Dear Editor,

One of the major factors driving the cost of healthcare upward in developing countries is aging population.[1] Policy makers and health-care providers face the challenge of optimally allocating scarce health-care resources over competing alternatives for elderly population. Research work has been conducted in India depicting the quality-adjusted life years (QALYs) of the elderly population within the context of various therapeutic areas;[2],[3] however, there is a lack of research which specifically assesses the cost-effectiveness of health care for the elderly.

While QALYs represent the most acceptable outcome for use in an economic evaluation, we also need to look at the measures which capture the benefits of health and social care interventions for the well-being of older people. Since elderly are more prone for diseases such as diabetes mellitus and hypertension, the economic burden of these diseases is also expected to be greater in such population.[4] In such context, economic evaluation indicates that the addition of pharmaceutical care in the core health team will not increase total direct health costs, yet will improve the health outcomes.[5] Heart failure among elderly poses such significant financial burden that efficient resource allocation for its diagnosis and treatment is a major societal and governmental challenge. Cost-effectiveness of falls prevention strategies has been done [6] but not in an Indian setting. It is also time to establish the cost-utility of minimal psychological interventions and also vaccinations for elderly persons.[7]

To conclude, since economic evaluations can support policy makers for the optimal allocation of health and social care resources within limited budgets, there is a need for well-designed reliable economic evaluation research for healthcare of elderly in particular, to support decision-making on the long-term financing and planning of these programs.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Global Health and Aging. WHO Report. Available from: http://www.who.int/ageing/publications/global_health.pdf. [Last accessed on 2016 Dec 03].  Back to cited text no. 1
Dang A, Likhar N, Alok U. Importance of economic evaluation in health care: An Indian perspective. Value Health Reg Issues 2016;9:78-83.  Back to cited text no. 2
Altaf M, Zubedi AM, Nazneen F, Kareemulla S, Ali SA, Aleemuddin NM, et al. Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India. Perspect Clin Res 2015;6:150-8.  Back to cited text no. 3
[PUBMED]  [Full text]  
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005;365:217-23.  Back to cited text no. 4
Obreli-Neto PR, Marusic S, Guidoni CM, Baldoni Ade O, Renovato RD, Pilger D, et al. Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: A 36-month randomized controlled clinical trial. J Manag Care Spec Pharm 2015;21:66-75.  Back to cited text no. 5
Frick KD, Kung JY, Parrish JM, Narrett MJ. Evaluating the cost-effectiveness of fall prevention programs that reduce fall-related hip fractures in older adults. J Am Geriatr Soc 2010;58:136-41.  Back to cited text no. 6
Middleton DB, Lin CJ, Smith KJ, Zimmerman RK, Nowalk MP, Roberts MS, et al. Economic evaluation for pneumococcal vaccination of hospitalized elderly patients. Infect Control Hosp Epidemiol 2008;29:385-94.  Back to cited text no. 7

This article has been cited by
1 Requirement of considering the ethical issues in elderly health care policy
Forouzan Akrami
International Journal of Preventive Medicine. 2019; 10(1): 25
[Pubmed] | [DOI]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article

 Article Access Statistics
    PDF Downloaded167    
    Comments [Add]    
    Cited by others 1    

Recommend this journal